Skip to main content
. 2023 Aug 8;20(1):2243252. doi: 10.1080/15502783.2023.2243252

Figure 3.

Figure 3.

a) Differences between treatment groups in the VR-12 MCS at baseline, 3 months, 6 months, and 9 months, with reported p-value for group by time interaction. (b) Differences between low frequency exercisers in treatment groups in MCS at baseline, 3 months, and 6 months. (c) Differences between high frequency exercisers in treatment groups in MCS at baseline, 3 months, and 6 months, with p-value for group by time interaction. (d) Differences between low frequency exercisers in treatment groups in MCS at baseline, 3 months, 6 months, and 9 months. (e) Differences between high frequency exercisers in treatment groups in MCS at baseline, 3 months, 6 months, and 9 months, with p-value for group by time interaction. AU = arbitrary units, g = grams, d = day, MCS = mental component score, LF = low frequency, HF = high frequency.